Glaxosmithkline

Pic:getty/imagesbytangmingtung

Positive booster data for Sanofi/GSK COVID-19 vaccine

By Rachel Arthur

A single booster dose of Sanofi and GSK’s recombinant adjuvanted COVID-19 vaccine candidate delivered ‘consistently strong immune responses’, according to data released by the companies.

Pic:getty/nezman

GSK to help manufacture Novavax COVID-19 vaccine

By Rachel Arthur

GSK will help manufacture up to 60 million doses of Novavax’s COVID-19 vaccine from its facility at Barnard Castle in the UK, with doses to be distributed in the country.

Pic:getty/alekesejplantanov

Sanofi to help manufacture Janssen COVID-19 vaccine

By Rachel Arthur

Sanofi’s vaccine manufacturing plant in Marcy l’Etoile, France, will formulate and fill vials of Janssen’s COVID-19 vaccine: producing around 12 million doses a month to help address global supply demands.

GSK House in Brentford, UK (source GSK)

update - comment from Unite

GSK says UK manufacturing cuts not Brexit related

By Gareth Macdonald

GSK has announced a shakeup of its UK network, shelving plans for Ulverston biopharma plant, mooting the sale of its cephalosporin antibiotics business and pledging to invest in HIV and respiratory drug capacity.